<DOC>
	<DOCNO>NCT01916837</DOCNO>
	<brief_summary>In prospective study investigator seek evaluate feasibility use genomic signature - Genomic Grade Index ( GGI ) - routine clinical practice impact treatment recommendation .</brief_summary>
	<brief_title>Genomic Grade Index ( GGI ) : Feasibility Routine Practice Impact Treatment Decisions Early Breast Cancer</brief_title>
	<detailed_description>The primary objective study evaluate feasibility implement Genomic Grade Index ( GGI ) community hospital Belgium breast cancer patient node negative 1-3 node positive early breast cancer . GGI would consider feasible genomic test result obtain &gt; 70 % evaluated patient .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Histologically confirm invasive breast cancer meeting follow criterion : T1 , T2 , operable T3 disease Zero three positive lymph node distant metastasis Operable disease Must undergone breastconserving surgery mastectomy either sentinel node procedure full axillary clearance No invasive cancer within past 5 year except adequately treat carcinoma situ cervix non melanoma skin cancer No psychological , familial , sociological , geographical condition would preclude enter clinical study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Breast cancer</keyword>
	<keyword>Feasibility</keyword>
	<keyword>Genomic grade index</keyword>
</DOC>